Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma

被引:0
作者
Frank Serge Lehmann [1 ]
Francesca Trapani [2 ]
Ida Fueglistaler [3 ]
Luigi Maria Terracciano [2 ]
Markus von Flüe [3 ]
Gieri Cathomas [4 ]
Andreas Zettl [5 ]
Pascal Benkert [6 ]
Daniel Oertli [7 ]
Christoph Beglinger [1 ]
机构
[1] Division of Gastroenterology and Hepatology,University Hospital,4031 Basel,Switzerland
[2] Institute of Pathology,University Hospital,4003 Basel,Switzerland
[3] St.Clara Hospital,4016 Basel,Switzerland  4. Institute of Pathology,University Hospital,4410 Liestal,Switzerland  5. Institute of Pathology,Viol
关键词
Calprotectin; Colorectal cancer; Inflammation; Tumor size; Granulocytes;
D O I
暂无
中图分类号
R735.37 [];
学科分类号
100214 ;
摘要
AIM:To determine calprotectin release before and after colorectal cancer operation and compare it to tumor and histopathological parameters.METHODS:The study was performed on patients with diagnosed colorectal cancer admitted for operation.Calprotectin was measured in a single stool sample before and three months after the operation using an enzymelinked immunosorbent assay(ELISA).Calprotectin levels greater than or equal to 50μg/g were considered positive.The compliance for collecting stool samples was assessed and the value of calprotectin was correlated to tumor and histopathological parameters of intra-and peri-tumoral inflammation.Surgical specimens were fixed in neutral buffered formalin and stained with hematoxylin and eosin.Staging was performed according to the Dukes classification system and the 7th edition tumor node metastasis classification system.Intra-and peri-tumoral inflammation was graded according to the Klintrup criteria.Immunohistochemical quantification was performed for MPO,CD45R0,TIA-1,CD3,CD4,CD8,CD57,and granzyme B.Statistical significance was measured using Wilcoxon signed rank test,Kruskal Wallis test and Spearman’s rank correlation coefficient as appropriate.RESULTS:Between March 2009 and May 2011,80 patients with colorectal cancer(46 men and 34 women,with mean age of 71±11.7 years old)were enrolled in the study.Twenty-six patients had rectal carcinoma,29 had left-side tumors,23 had right-side tumors,and2 had bilateral carcinoma.In total,71.2%of the patients had increased levels of calprotectin before the operation(median 205μg/g,range 50-2405μg/g)and experienced a significant decrease three months after the operation(46μg/g,range 10-384μg/g,P<0001).The compliance for collecting stool samples was 89.5%.Patients with T3 and T4 tumors had significantly higher values than those with T1 and T2 cancers(P=0.022).For all other tumor parameters(N,M,G,L,V,Pn)and location,no significant difference in calprotectin concentration was found.Furthermore,the calprotectin levels and histological grading of both peri-and intra-tumoral inflammation was not correlated.Additional testing with specific markers for lymphocytes and neutrophils also revealed no statistically significant correlation.CONCLUSION:Fecal calprotectin decreases significantly after colorectal cancer operation.Its value depends exclusively on the individual T-stage,but not on other tumor or histopathological parameters.
引用
收藏
页码:4994 / 4999
页数:6
相关论文
共 16 条
[1]  
The relationship between tumour site, clinicopathological characteristics and cancer‐specific survival in patients undergoing surgery for colorectal cancer[J] . A. G. M. T. Powell,R. Wallace,R. F. McKee,J. H. Anderson,J. J. Going,J. Edwards,P. G. Horgan.Colorectal Disease . 2012 (12)
[2]   Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer [J].
Richards, C. H. ;
Roxburgh, C. S. D. ;
Anderson, J. H. ;
Mckee, R. F. ;
Foulis, A. K. ;
Horgan, P. G. ;
McMillan, D. C. .
BRITISH JOURNAL OF SURGERY, 2012, 99 (02) :287-294
[3]  
Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers[J] . Petr Ricanek,Stephan Brackmann,G&oslash,ri Perminow,Lars G. Lyckander,Jon Sponheim,&oslash,yvind Holme,Ole H&oslash,ie,Andreas Rydning,Morten H. Vatn.Scandinavian Journal of Gastroenterology . 2011 (9)
[4]   The Relationship Between the Local and Systemic Inflammatory Responses and Survival in Patients Undergoing Curative Surgery for Colon and Rectal Cancers [J].
Roxburgh, Campbell S. D. ;
Salmond, Jonathan M. ;
Horgan, Paul G. ;
Oien, Karin A. ;
McMillan, Donald C. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2009, 13 (11) :2011-2018
[5]  
Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease[J] . J.P. Gisbert,A.G. McNicholl.Digestive and Liver Disease . 2008 (1)
[6]   Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases [J].
Damms, A. ;
Bischoff, S. C. .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (10) :985-992
[7]   Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease [J].
D'Inca, Renata ;
Dal Pont, Elisabetta ;
Di Leo, Vincenza ;
Ferronato, Antonio ;
Fries, Walter ;
Vettorato, Maria Grazia ;
Martines, Diego ;
Sturniolo, Giacomo Carlo .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (04) :429-437
[8]   Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease [J].
Tibble, JA ;
Sigthorsson, G ;
Foster, R ;
Forgacs, I ;
Bjarnason, I .
GASTROENTEROLOGY, 2002, 123 (02) :450-460
[9]  
Fecal Calprotectin: Validation as a Noninvasive Measure of Bowel Inflammation in Childhood Inflammatory Bowel Disease[J] . Susan K. Bunn,W. Michael Bisset,Margaret J. C. Main,Elizabeth S. Gray,Shona Olson,Barbara E. Golden.Journal of Pediatric Gastroenterology and Nutrition . 2001 (1)
[10]  
A New Fecal Calprotectin Test for Colorectal Neoplasia: Clinical Results and Comparison with Previous Method[J] . B. Johne, O. Kronborg, H. I. T&oslash,n, J. Kristinsson, P. Fuglerud.Scandinavian Journal of Gastroenterology . 2001 (3)